Natasha Krishnadas - The Florey Institute of Neuroscience and Mental Health, University of Melbourne

基本信息

Career Trajectory

Bio

I am a Neurologist with sub-specialty training in Cognitive Neurology. My clinical expertise are in the evaluation and management of dementia and as a clinical trials sub-investigator. My PhD focused on amyloid and tau PET imaging in mixed 3R/4R tauopathies (Alzheimer's, PART, and CTE). My post-doctoral work at the Florey Institute was in PET and blood-based biomarkers. My overall research interest is in the translation of biomarker research for neurodegenerative diseases into clinical practice.

Research Interests

Papers共 58 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Clinical Evidence for GLP-1 Receptor Agonists in Alzheimer's Disease: A Systematic Review

Yulin Liang,Vincent Dore,Christopher C. Rowe,Natasha Krishnadas

JOURNAL OF ALZHEIMERS DISEASE REPORTSno. 1 (2024): 777-789

Cited0Views0WOSBibtex

Aβ-Amyloid Lowering with Monoclonal Antibodies for Alzheimer's Disease: Appropriate Use Recommendations for Australasian Conditions

Colin Masters, Lavier Gomes, Nick Holford,Natasha Krishnadas,Sue Kurrle, Dimity Pond, Cathy Roth,Christopher C. Rowe,Perminder S. Sachdev, Cathy Short,Michael Woodward

SSRN Electronic Journal (2024)

Cited0Views0Bibtex

Plasma Biomarkers in Chronic Single Moderate-Severe Traumatic Brain Injury

Gershon Spitz,Amelia J. Hicks,Stuart J. McDonald,Vincent Dore,Natasha Krishnadas,Terence J. O'Brien,William T. O'Brien,Lucy Vivash,Meng Law,Jennie L. Ponsford,Christopher Rowe,Sandy R. Shultz

Brain a journal of neurologyno. 11 (2024): 3641-3642

Cited0Views0WOSBibtex

Alzheimer’s Disease biological PET staging using plasma p217+tau

Azadeh Feizpour,Vincent Doré,Natasha Krishnadas,Pierrick Bourgeat,James D. Doecke,Ziad S. Saad,Gallen Triana-Baltzer,Simon M. Laws,Rosita Shishegar,Kun Huang,Christopher Fowler,Larry Ward,Colin L. Masters,Jurgen Fripp,Hartmuth C. Kolb,Victor L. Villemagne,Christopher C. Rowe

medrxiv（2024）

Cited0Views0Bibtex

Alzheimer’s Disease Biological PET Staging Using Plasma P217+tau

medrxiv（2024）

Cited0Views0Bibtex

Cross-Sectional and Longitudinal Comparison of Tau Imaging with F-18-MK6240 and F-18-Flortaucipir in Populations Matched for Age, MMSE and Brain Beta-Amyloid Burden

Pierrick Bourgeat,N. Krishnadas,V. Dore,R. Mulligan, R. Tyrrell, S. Bozinovski, K. Huang,J. Fripp,V. L. Villemagne,C. C. Rowe,Alzheimers Dis Neuroimaging Initiat, A. I. B. L. Res Grp

JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2023)

Cited0Views0Bibtex

Tau PET: Utility As a Biomarker for Chronic Traumatic Encephalopathy

Natasha Krishnadas,Vincent Doré,Fiona Lamb,Rodney Guzman,Jennie Ponsford,Amelia J. Hicks,Robert Williams,Azadeh Feizpour,Victor L. Villemagne,Christopher C. Rowe

Alzheimer's & dementiano. S16 (2023)

Cited0Views0Bibtex

Two-Year Prognostic Utility of Plasma P217+tau Across the Alzheimer’s Continuum

A. Feizpour,V. Dore,J. D. Doecke,Z. S. Saad,G. Triana-Baltzer, R. Slemmon,P. Maruff,N. Krishnadas,P. Bourgeat, K. Huang,C. Fowler,S. R. Rainey-Smith,A. I. Bush, L. Ward,J. Robertson,R. N. Martins,C. L. Masters,V. L. Villemagne,J. Fripp,H. C. Kolb,Christopher C. Rowe

Research Square (Research Square) (2023)

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn